452 - PREVALENCE AND CLINICAL IMPLICATIONS OF ANEMIA IN CHF PATIENTS
W Elabbassi, L Meilniczuk, C Williams, M Fraiser, H Haddad
Ottawa, Ontario

453 - PREVALENCE OF LOW T3 LEVELS AMONG HYPOTHYROID CHF PATIENTS ON THYROXINE TREATMENT
W Elabbassi, L Mielniczuk, C Williams, M Fraiser, H Haddad
Ottawa, Ontario

454 - COMPARISON OF TROUGH AND PEAK CYCLOSPORINE LEVELS AFTER HEART TRANSPLANTATION
RA Davies, K Williams, A Baker, J Donaldson, J Veinot, H Haddad, C Struthers, R Masters, P Hendry, T Mesana
Ottawa, Ontario

455 - NEW HEART FAILURE DISEASE MANAGEMENT PROGRAM REDUCES MORBIDITY AND HOSPITALIZATIONS
MC Chan, K O’Reilly, T Fenske, A Jones, R Williams, S Sivakumaran, R Gutierrez, D Knot, J Amelio
Edmonton, Alberta

456 - LEFT VENTRICULAR ENLARGEMENT IN AUTOSOMAL DOMINANT ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
K Hodgkinson, P Parfrey, A Bassett, S Stuckless, S Fagan, L Thierfelder, S Connors
St John’s, Newfoundland

457 - PREVALENCE OF ANEMIA AND OTHER CO-MORBID CONDITIONS IN PATIENTS WITH SEVERE HEART FAILURE IN AN OUTPATIENT HEART FAILURE CLINIC
K Vijayaraghavan, S Crum, M Jeffries, L Barnett-Avery
Phoenix, Arizona, USA

458 - IS LEFT VENTRICULAR END-DIASTOLIC PRESSURE (LVEDP) OR ITS DERIVATIVES AN ACCURATE SURROGATE OF THE PULMONARY ARTERY WEDGE PRESSURE (PAWP)
S Prasad, S Khanal, J Dias, M Mandawat, D Kapoor, J Thornton III, H Williams, G Pineda, V Robinson
Augusta, Georgia, USA

459 - SYSTEMIC RIGHT VENTRICULAR DYSFUNCTION POST ATRIAL SWITCH FOR ISOLATED D-TRANSPOSITION OF THE GREAT ARTERIES: THE IMPACT OF BETA-BLOCKADE
CB Josephson, JG Howlett, SD Jackson, J Finley, CM Kells
Halifax, Nova Scotia